secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001213900-23-058024
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. extends business combination deadline to July 14, 2024 after stockholder vote
--------------------------------------------------------------------------------

- Stockholders approved extension of deadline from July 19, 2023 to July 14, 2024 via charter and trust amendment.
- 161,566 shares of common stock were redeemed in connection with the extension vote.
- Monthly deposit of $0.05 per public share into trust account required during extension period.
- Re-elected directors Tao Jiang and James as Class II directors for three-year term.
- Ratified Marcum LLP as independent auditor for fiscal year ending December 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023058024/0001213900-23-058024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023058024/ea181964-8k_tradeupacq.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-058024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer